OCS ▲ +2.8% - Oculis Holding AG
$OCS - Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting
20-OCT-2026 02:00 AM ET
Share this post
More filings for $OCS
OCS ▼ -1.4% - Oculis Holding AGOct 19, 2026OCS ▲ +1.6% - Oculis Holding AGOct 7, 2026OCS ▲ +2.1% - Oculis Holding AGOct 1, 2026
View full $OCS filing history →💬 Comments
Loading comments…
Leave a comment